Estimate patient’s 10-year ASCVD risk at an initial visit to establish a reference point. Forecast the potential impact of different interventions on patient risk.

Click the Terms tab at the bottom of the app before using the LDL-C Lowering Therapy, Hypertriglyceridemia, Statin Intolerance, or ASCVD Risk Estimator tools in the Lipid Manager (“the …

All fields are required to compute ASCVD risk. Gender

LDL-C Lowering Therapy Assess response to statin and appropriateness of additional therapy

Given the benefits of statins in ASCVD risk reduction, clinicians should partner with the patient to gain a thorough symptom history and determine if he or she is truly statin intolerant.